Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA
Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
Arch Clin Neuropsychol. 2016 Jun;31(4):313-31. doi: 10.1093/arclin/acw014. Epub 2016 Apr 15.
The objective is to examine failure on three embedded performance validity tests [Reliable Digit Span (RDS), Auditory Verbal Learning Test (AVLT) logistic regression, and AVLT recognition memory] in early Alzheimer disease (AD; n = 178), amnestic mild cognitive impairment (MCI; n = 365), and cognitively intact age-matched controls (n = 206).
Neuropsychological tests scores were obtained from subjects participating in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
RDS failure using a ≤7 RDS threshold was 60/178 (34%) for early AD, 52/365 (14%) for MCI, and 17/206 (8%) for controls. A ≤6 RDS criterion reduced this rate to 24/178 (13%) for early AD, 15/365 (4%) for MCI, and 7/206 (3%) for controls. AVLT logistic regression probability of ≥.76 yielded unacceptably high false-positive rates in both clinical groups [early AD = 149/178 (79%); MCI = 159/365 (44%)] but not cognitively intact controls (13/206, 6%). AVLT recognition criterion of ≤9/15 classified 125/178 (70%) of early AD, 155/365 (42%) of MCI, and 18/206 (9%) of control scores as invalid, which decreased to 66/178 (37%) for early AD, 46/365 (13%) for MCI, and 10/206 (5%) for controls when applying a ≤5/15 criterion. Despite high false-positive rates across individual measures and thresholds, combining RDS ≤ 6 and AVLT recognition ≤9/15 classified only 9/178 (5%) of early AD and 4/365 (1%) of MCI patients as invalid performers.
Embedded validity cutoffs derived from mixed clinical groups produce unacceptably high false-positive rates in MCI and early AD. Combining embedded PVT indicators lowers the false-positive rate.
本研究旨在检验三种嵌入式效度量表[可靠数字跨度(RDS)、听觉词语学习测验(AVLT)逻辑回归和 AVLT 再认记忆]在早期阿尔茨海默病(AD;n=178)、遗忘型轻度认知障碍(MCI;n=365)和认知正常的年龄匹配对照组(n=206)中的失败情况。
从参与阿尔茨海默病神经影像学倡议(ADNI)的受试者中获得神经心理学测试分数。
使用≤7 RDS 阈值的 RDS 失败率在早期 AD 中为 60/178(34%),在 MCI 中为 52/365(14%),在对照组中为 17/206(8%)。将≤6 RDS 标准降低至早期 AD 为 24/178(13%)、MCI 为 15/365(4%)和对照组为 7/206(3%)。AVLT 逻辑回归概率≥.76 在两个临床组中产生了不可接受的高假阳性率[早期 AD=149/178(79%);MCI=159/365(44%)],但在认知正常的对照组中没有(13/206,6%)。AVLT 再认标准≤9/15 将 125/178(70%)的早期 AD、155/365(42%)的 MCI 和 18/206(9%)的对照组得分分类为无效,当应用≤5/15 标准时,早期 AD 降至 66/178(37%)、MCI 降至 46/365(13%)和对照组降至 10/206(5%)。尽管个别测量和阈值的假阳性率较高,但将 RDS≤6 和 AVLT 再认≤9/15 相结合,仅将 9/178(5%)的早期 AD 和 4/365(1%)的 MCI 患者分类为无效表现者。
从混合临床组中得出的嵌入式效度量表产生了不可接受的高假阳性率在 MCI 和早期 AD 中。结合嵌入式 PVT 指标可降低假阳性率。